Personal information

Other IDs

Scopus Author ID: 55756975600
Researcher ID: ABC-3018-2021
Scopus Author ID: 55756975600

Countries

Israel

Activities

Collapse all

Employment (2)

Ben-Gurion University of the Negev: Beer-Sheva, Southern, IL

2021-10-01 to present (Department of Software and Information Systems Engineering)
Employment
Source: check_circle
Ben-Gurion University of the Negev

Clalit Health Services: Tel Aviv, Tel Aviv, IL

2015-03-01 to present | Head of data & AI driven medicine (Clalit Research Institute)
Employment
Source: Self-asserted source
Noa Dagan

Education and qualifications (5)

Harvard Medical School: Boston, MA, US

2020 to 2021 | Postdoctoral Fellowship (The Department of Biomedical Informatics (DBMI))
Education
Source: Self-asserted source
Noa Dagan

Ben-Gurion University of the Negev: Beer-Sheva, Southern, IL

2016 to 2020 | PhD (Computer Science)
Education
Source: Self-asserted source
Noa Dagan

Hebrew University Faculty of Medicine: Jerusalem, Jerusalem, IL

2005 to 2012 | Medical Doctor (MD) (Medicine)
Education
Source: Self-asserted source
Noa Dagan

Hebrew University Faculty of Medicine: Jerusalem, Jerusalem, IL

2009 to 2010 | Master in Public Health
Education
Source: Self-asserted source
Noa Dagan

Hebrew University of Jerusalem: Jerusalem, IL

2005 to 2008 | Bachelor of Medical Science (B.Med.Sc) (Faculty of Medicine)
Education
Source: Self-asserted source
Noa Dagan

Works (48)

Trends of common laboratory biomarkers after SARS-CoV-2 infection

Journal of Infection
2024-12-01 | Journal article | Author
DOI: 10.1016/j.jinf.2024.106318
SOURCE-WORK-ID:

e3e6084c-8872-4185-b089-c190842e98d7

EID:

2-s2.0-85206973649

PMID: 39423876
Contributors: Tomer Meirman; Bracha Shapira; Ran D. Balicer; Lior Rokach; Noa Dagan
Source: check_circle
Ben-Gurion University of the Negev - Pure

Evaluation of AI Solutions in Health Care Organizations — The OPTICA Tool

NEJM AI
2024-08-22 | Journal article
DOI: 10.1056/AIcs2300269
Contributors: Noa Dagan; Stav Devons-Sberro; Ziv Paz; Lilach Zoller; Adir Sommer; Galit Shaham; Nir Shahar; Reut Ohana; Orly Weinstein; Doron Netzer et al.
Source: check_circle
Crossref

Development and Validation of a Colorectal Cancer Prediction Model

Digestive Diseases and Sciences
2024-07-01 | Journal article | Author
DOI: 10.1007/s10620-024-08427-4
SOURCE-WORK-ID:

6a8ab5cd-681f-4598-829d-1ea210e058f4

EID:

2-s2.0-85191305009

PMID: 38662163
Contributors: Ofer Isakov; Dan Riesel; Michael Leshchinsky; Galit Shaham; Ben Y. Reis; Dan Keret; Zohar Levi; Baruch Brener; Ran Balicer; Noa Dagan et al.
Source: check_circle
Ben-Gurion University of the Negev - Pure

Implementation of AZD7442 (Tixagevimab/Cilgavimab) COVID-19 Pre-exposure Prophylaxis (PrEP) in the Largest Health Maintenance Organization in Israel

Infectious Diseases and Therapy
2024-06-01 | Journal article | Author
DOI: 10.1007/s40121-024-00981-8
SOURCE-WORK-ID:

ad255052-aeae-4eb3-a2b3-b82e737fea77

EID:

2-s2.0-85192798986

PMID: 38728006
Contributors: Samah Hayek; Joseph Levy; Galit Shaham; Noa Dagan; Danielle Serby; Hadar Duskin-Bitan; Adva Yarden; Cátia Ferreira; Idit Livnat; Sabada Dube et al.
Source: check_circle
Ben-Gurion University of the Negev - Pure

Why We Support and Encourage the Use of Large Language Models in NEJM AI Submissions

NEJM AI
2024-01 | Journal article
DOI: 10.1056/AIe2300128
Contributors: Daphne Koller; Andrew Beam; Arjun Manrai; Euan Ashley; Xiaoxuan Liu; Judy Gichoya; Chris Holmes; James Zou; Noa Dagan; Tien Y. Wong et al.
Source: check_circle
Crossref

Prospective Evaluation of Machine Learning for Public Health Screening: Identifying Unknown Hepatitis C Carriers

NEJM AI
2024-01-25 | Journal article
DOI: 10.1056/AIoa2300012
Contributors: Noa Dagan; Ori Magen; Michael Leshchinsky; Maya Makov-Assif; Marc Lipsitch; Ben Y. Reis; Shlomit Yaron; Doron Netzer; Ran D. Balicer
Source: check_circle
Crossref

Comparing COVID-19-related hospitalization rates among individuals with infection-induced and vaccine-induced immunity in Israel

Nature Communications
2022-12-01 | Journal article | Author
DOI: 10.1038/s41467-022-29858-5
SOURCE-WORK-ID:

69dfb27f-ba6b-4aad-b12d-68e70d4a1e03

EID:

2-s2.0-85128701150

PMID: 35459237
Contributors: Jacob G. Waxman; Maya Makov-Assif; Ben Y. Reis; Doron Netzer; Ran D. Balicer; Noa Dagan; Noam Barda
Source: check_circle
Ben-Gurion University of the Negev - Pure

Effectiveness of first-generation severe acute respiratory syndrome coronavirus 2 mRNA vaccines against the Omicron variant

Clinical Microbiology and Infection
2022-12-01 | Other | Author
DOI: 10.1016/j.cmi.2022.08.017
SOURCE-WORK-ID:

79db28a9-4881-4d27-a02e-783ef984fe94

EID:

2-s2.0-85139369868

PMID: 36038121
Contributors: Noa Dagan; Noam Barda
Source: check_circle
Ben-Gurion University of the Negev - Pure

Effectiveness of REGEN-COV antibody combination in preventing severe COVID-19 outcomes

Nature Communications
2022-12-01 | Journal article | Author
DOI: 10.1038/s41467-022-32253-9
SOURCE-WORK-ID:

f5dddc0c-4723-45bc-8df1-9a2c1e324791

EID:

2-s2.0-85135214656

PMID: 35918340
Contributors: Samah Hayek; Yatir Ben-shlomo; Noa Dagan; Ben Y. Reis; Noam Barda; Eldad Kepten; Alina Roitman; Shachar Shapira; Shlomit Yaron; Ran D. Balicer et al.
Source: check_circle
Ben-Gurion University of the Negev - Pure

Myocarditis after BNT162b2 Vaccination in Israeli Adolescents

New England Journal of Medicine
2022-11-10 | Journal article | Author
DOI: 10.1056/NEJMc2207270
SOURCE-WORK-ID:

8578ad96-a37e-4a04-b623-189110555faa

EID:

2-s2.0-85141893288

PMID: 36260842
Contributors: Guy Witberg; Ori Magen; Sara Hoss; Yeela Talmor-Barkan; Ilan Richter; Maya Wiessman; Yaron Aviv; Tzlil Grinberg; Arthur Shiyovich; Nili Schamroth-Pravda et al.
Source: check_circle
Ben-Gurion University of the Negev - Pure

Myocarditis following COVID-19 vaccine

European Journal of Heart Failure
2022-11-01 | Journal article | Author
DOI: 10.1002/ejhf.2669
SOURCE-WORK-ID:

242bf3d4-dbbc-4b30-a7ef-f1f4c918ef0c

EID:

2-s2.0-85139442064

PMID: 36065751
Contributors: Bettina Heidecker; Noa Dagan; Ran Balicer; Urs Eriksson; Giuseppe Rosano; Andrew Coats; Carsten Tschöpe; Sebastian Kelle; Gregory A. Poland; Andrea Frustaci et al.
Source: check_circle
Ben-Gurion University of the Negev - Pure

BNT162b2 vaccine effectiveness in chronic kidney disease patients—an observational study

CKJ: Clinical Kidney Journal
2022-10-01 | Journal article | Author
DOI: 10.1093/ckj/sfac166
SOURCE-WORK-ID:

d45db9b5-145e-470a-ba60-1d6dfb63a025

EID:

2-s2.0-85153950153
Contributors: Dana Bielopolski; Gilad Libresco; Noam Barda; Noa Dagan; Tali Steinmetz; Dafna Yahav; David M. Charytan; Ran D. Balicer; Benaya Rozen-Zvi
Source: check_circle
Ben-Gurion University of the Negev - Pure

Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron Surge

New England Journal of Medicine
2022-09-01 | Journal article | Author
DOI: 10.1056/NEJMoa2204919
SOURCE-WORK-ID:

10977d4c-56d6-4d4b-9cfb-4aca07da065c

EID:

2-s2.0-85137153610

PMID: 36001529
Contributors: Ronen Arbel; Yael Wolff Sagy; Moshe Hoshen; Erez Battat; Gil Lavie; Ruslan Sergienko; Michael Friger; Jacob G. Waxman; Noa Dagan; Ran Balicer et al.
Source: check_circle
Ben-Gurion University of the Negev - Pure
grade
Preferred source (of 2)‎

Improving Cardiovascular Disease Prediction Using Automated Coronary Artery Calcium Scoring from Existing Chest CTs

Journal of Digital Imaging
2022-08-01 | Journal article | Author
DOI: 10.1007/s10278-021-00575-7
SOURCE-WORK-ID:

c5996fef-0e66-44ef-8976-32cf0d4ec6d2

EID:

2-s2.0-85126373902

PMID: 35296940
Contributors: Noam Barda; Noa Dagan; Amos Stemmer; Janni Yuval; Eitan Bachmat; Eldad Elnekave; Ran Balicer
Source: check_circle
Ben-Gurion University of the Negev - Pure

BNT162b2 Vaccine Effectiveness against Omicron in Children 5 to 11 Years of Age

New England Journal of Medicine
2022-07-21 | Journal article | Author
DOI: 10.1056/NEJMoa2205011
SOURCE-WORK-ID:

2e60600e-e257-4794-90d5-7a2b3b83ab15

EID:

2-s2.0-85134854253

PMID: 35767475
Contributors: Chandra J. Cohen-Stavi; Ori Magen; Noam Barda; Shlomit Yaron; Alon Peretz; Doron Netzer; Carlo Giaquinto; Ali Judd; Leonard Leibovici; Miguel A. Hernán et al.
Source: check_circle
Ben-Gurion University of the Negev - Pure

Incidence of lung cancer following pneumonia in smokers

QJM: An International Journal of Medicine
2022-05-01 | Journal article | Author
DOI: 10.1093/qjmed/hcab030
SOURCE-WORK-ID:

e7325cd2-b9ee-46da-bc08-e6bd2b94aa51

EID:

2-s2.0-85130001507

PMID: 33576784
Contributors: D. Shepshelovich; Noam Barda; H. Goldvaser; Noa Dagan; A. Zer; T. Diker-Cohen; R. Balicer; A. Gafter-Gvili
Source: check_circle
Ben-Gurion University of the Negev - Pure

Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting

New England Journal of Medicine
2022-04-28 | Journal article | Author
DOI: 10.1056/NEJMoa2201688
SOURCE-WORK-ID:

029a0ee5-b3f5-4c82-aaac-cbc4daf634a6

EID:

2-s2.0-85129772328

PMID: 35417631
Contributors: Ori Magen; Jacob G. Waxman; Maya Makov-Assif; Roni Vered; Dror Dicker; Miguel A. Hernán; Marc Lipsitch; Ben Y. Reis; Ran D. Balicer; Noa Dagan
Source: check_circle
Ben-Gurion University of the Negev - Pure
grade
Preferred source (of 2)‎

Validation of Heart Failure-Specific Risk Equations in 1.3 Million Israeli Adults and Usefulness of Combining Ambulatory and Hospitalization Data from a Large Integrated Health Care Organization

American Journal of Cardiology
2022-04-01 | Journal article | Author
DOI: 10.1016/j.amjcard.2021.12.017
SOURCE-WORK-ID:

f09dce7e-006f-43b9-a234-ea8e89c714d4

EID:

2-s2.0-85122637942

PMID: 35031113
Contributors: Sadiya S. Khan; Noam Barda; Philip Greenland; Noa Dagan; Donald M. Lloyd-Jones; Ran Balicer; Laura J. Rasmussen-Torvik
Source: check_circle
Ben-Gurion University of the Negev - Pure
grade
Preferred source (of 2)‎

Indirect protection of children from SARS-CoV-2 infection through parental vaccination

Science
2022-03-11 | Journal article | Author
DOI: 10.1126/science.abm3087
SOURCE-WORK-ID:

ba897c7b-6e64-4d70-99f1-4aeefa84b360

EID:

2-s2.0-85126388881

PMID: 35084938
Contributors: Samah Hayek; Galit Shaham; Yatir Ben-Shlomo; Eldad Kepten; Noa Dagan; Daniel Nevo; Marc Lipsitch; Ben Y. Reis; Ran D. Balicer; Noam Barda
Source: check_circle
Ben-Gurion University of the Negev - Pure
grade
Preferred source (of 2)‎

Effectiveness of the BNT162b2mRNA COVID-19 vaccine in patients with hematological neoplasms in a nationwide mass vaccination setting

Blood
2022-03-10 | Journal article | Author
DOI: 10.1182/blood.2021013768
SOURCE-WORK-ID:

e71fbfbc-eaaa-4d26-a02e-3ba62a994bcc

EID:

2-s2.0-85125865462

PMID: 34662390
Contributors: Moshe Mittelman; Ori Magen; Noam Barda; Noa Dagan; Howard S. Oster; Avi Leader; Ran Balicer
Source: check_circle
Ben-Gurion University of the Negev - Pure
grade
Preferred source (of 2)‎

Previously undiagnosed cancer in patients with arterial thrombotic events – A population-based cohort study

Journal of Thrombosis and Haemostasis
2022-03-01 | Journal article | Author
DOI: 10.1111/jth.15600
SOURCE-WORK-ID:

da57757d-cec9-432e-9595-7634e1994dea

EID:

2-s2.0-85120671105

PMID: 34818468
Contributors: Avi Leader; Noa Dagan; Noam Barda; Idan Goldberg; Pia Raanani; Galia Spectre; Ran Balicer; Anat Gafter-Gvili
Source: check_circle
Ben-Gurion University of the Negev - Pure

The role of observational studies based on secondary data in studying SARS-CoV-2 vaccines

Clinical Microbiology and Infection
2022-03-01 | Other | Author
DOI: 10.1016/j.cmi.2021.12.006
SOURCE-WORK-ID:

e007b4c5-4b58-4de6-bde7-f613f4772c4f

EID:

2-s2.0-85121971300

PMID: 34906720
Contributors: Noam Barda; Noa Dagan
Source: check_circle
Ben-Gurion University of the Negev - Pure

Using population-level incidence of hepatitis C virus and immigration status for data-driven screening policies

Journal of Public Health
2022-03-01 | Journal article | Author
DOI: 10.1093/pubmed/fdaa215
SOURCE-WORK-ID:

0473e27c-c932-41aa-a5d1-27c9dff477f9

EID:

2-s2.0-85126072376

PMID: 33348364
Contributors: Maya Leventer-Roberts; Noa Dagan; Jenna M. Berent; Ilan Brufman; Moshe Hoshen; Marius Braun; Ran D. Balicer; Becca S. Feldman
Source: check_circle
Ben-Gurion University of the Negev - Pure

Early effectiveness of BNT162b2 Covid-19 vaccine in preventing SARS-CoV-2 infection in healthcare personnel in six Israeli hospitals (CoVEHPI)

Vaccine
2022-01-24 | Journal article | Author
DOI: 10.1016/j.vaccine.2021.11.092
SOURCE-WORK-ID:

f8936d61-daf4-442a-b7ef-095319f1bfd5

EID:

2-s2.0-85121136797

PMID: 34903372
Contributors: Mark A. Katz; Efrat Bron Harlev; Bibiana Chazan; Michal Chowers; David Greenberg; Alon Peretz; Sagi Tshori; Joseph Levy; Mili Yacobi; Avital Hirsch et al.
Source: check_circle
Ben-Gurion University of the Negev - Pure

Adverse effects after BNT162B2 vaccine and SARS-CoV-2 infection, according to age and sex

New England Journal of Medicine
2021-12-09 | Journal article | Author
DOI: 10.1056/NEJMc2115045
SOURCE-WORK-ID:

e6669f4a-1e53-4e0d-ba92-1af08d05accd

EID:

2-s2.0-85121141704

PMID: 34706169
Contributors: Noa Dagan; Noam Barda; Ran D. Balicer
Source: check_circle
Ben-Gurion University of the Negev - Pure
grade
Preferred source (of 2)‎

Myocarditis after covid-19 vaccination in a large health care organization

New England Journal of Medicine
2021-12-02 | Journal article | Author
DOI: 10.1056/NEJMoa2110737
SOURCE-WORK-ID:

20b2a8b3-1be7-43f8-9228-80fcb29443a5

EID:

2-s2.0-85117815441

PMID: 34614329
Contributors: Guy Witberg; Noam Barda; Sara Hoss; Ilan Richter; Maya Wiessman; Yaron Aviv; Tzlil Grinberg; Oren Auster; Noa Dagan; Ran D. Balicer et al.
Source: check_circle
Ben-Gurion University of the Negev - Pure
grade
Preferred source (of 2)‎

Effectiveness of BNT162B2 vaccine against delta variant in adolescents

New England Journal of Medicine
2021-11-25 | Journal article | Author
DOI: 10.1056/NEJMc2114290
SOURCE-WORK-ID:

ef109002-76ff-4c4c-9ca5-f7a6f5c7f49b

EID:

2-s2.0-85119106214

PMID: 34670036
Contributors: Ben Y. Reis; Noam Barda; Michael Leshchinsky; Eldad Kepten; Miguel A. Hernán; Marc Lipsitch; Noa Dagan; Ran D. Balicer
Source: check_circle
Ben-Gurion University of the Negev - Pure
grade
Preferred source (of 2)‎

The association between real-time reverse transcriptase polymerase chain reaction cycle threshold values, symptoms and disease severity among COVID-19 patients in the community: a retrospective cohort study

Infectious Diseases
2021-11-07 | Journal article
DOI: 10.1080/23744235.2021.1998606
Part of ISSN: 2374-4235
Part of ISSN: 2374-4243
Source: Self-asserted source
Noa Dagan
grade
Preferred source (of 2)‎

Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study

The Lancet
2021-10 | Journal article
DOI: 10.1016/s0140-6736(21)02249-2
Part of ISSN: 0140-6736
Source: Self-asserted source
Noa Dagan
grade
Preferred source (of 2)‎

Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancy

Nature Medicine
2021-10-01 | Journal article | Author
DOI: 10.1038/s41591-021-01490-8
SOURCE-WORK-ID:

a87b4f1f-2f30-413c-82e8-0d55619a4377

EID:

2-s2.0-85114643001

PMID: 34493859
Contributors: Noa Dagan; Noam Barda; Tal Biron-Shental; Maya Makov-Assif; Calanit Key; Isaac S. Kohane; Miguel A. Hernán; Marc Lipsitch; Sonia Hernandez-Diaz; Ben Y. Reis et al.
Source: check_circle
Ben-Gurion University of the Negev - Pure
grade
Preferred source (of 2)‎

Safety of the BNT162b2 mRNA Covid-19 vaccine in a nationwide setting

New England Journal of Medicine
2021-09-16 | Journal article | Author
DOI: 10.1056/NEJMoa2110475
SOURCE-WORK-ID:

f51370e4-2e2c-42cc-a683-4a819eb636fa

EID:

2-s2.0-85114403291

PMID: 34432976
Contributors: Noam Barda; Noa Dagan; Yatir Ben-Shlomo; Eldad Kepten; Jacob Waxman; Reut Ohana; Miguel A. Hernan; Marc Lipsitch; Isaac Kohane; Doron Netzer et al.
Source: check_circle
Ben-Gurion University of the Negev - Pure
grade
Preferred source (of 3)‎

MHC Haplotyping of SARS-CoV-2 Patients

Journal of Clinical Immunology
2021-08-01 | Journal article | Author
DOI: 10.1007/s10875-021-01071-x
SOURCE-WORK-ID:

606989ed-88ed-442b-ad73-f080342c7c3f

EID:

2-s2.0-85107304081

PMID: 34050837
Contributors: Shay Ben Shachar; Noam Barda; Sigal Manor; Sapir Israeli; Noa Dagan; Shai Carmi; Ran Balicer; Bracha Zisser; Yoram Louzoun
Source: check_circle
Ben-Gurion University of the Negev - Pure
grade
Preferred source (of 4)‎

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting. Reply

The New England journal of medicine
2021-05-20 | Journal article | Author
DOI: 10.1056/NEJMc2104281
SOURCE-WORK-ID:

7e3207e9-6a67-4b17-98e5-54e5437fa6e4

EID:

2-s2.0-85107084965

PMID: 33882227
Contributors: Noam Barda; Noa Dagan; Ran D. Balicer
Source: check_circle
Ben-Gurion University of the Negev - Pure
grade
Preferred source (of 2)‎

BNT162B2 mRNA covid-19 vaccine in a nationwide mass vaccination setting

New England Journal of Medicine
2021-04-15 | Journal article | Author
DOI: 10.1056/NEJMoa2101765
SOURCE-WORK-ID:

2f476c4c-82dc-40a6-bbf5-6e722bdb7a5c

EID:

2-s2.0-85103719376

PMID: 33626250
Contributors: Noa Dagan; Noam Barda; Eldad Kepten; Oren Miron; Shay Perchik; Mark A. Katz; Miguel A. Hernán; Marc Lipsitch; Ben Reis; Ran D. Balicer
Source: check_circle
Ben-Gurion University of the Negev - Pure
grade
Preferred source (of 2)‎

Addressing bias in prediction models by improving subpopulation calibration

Journal of the American Medical Informatics Association
2021-03-01 | Journal article | Author
DOI: 10.1093/jamia/ocaa283
SOURCE-WORK-ID:

e9d14798-1b8c-4f09-85bd-ee955ddb7f4b

EID:

2-s2.0-85102657293

PMID: 33236066
Contributors: Noam Barda; Gal Yona; Guy N. Rothblum; Philip Greenland; Morton Leibowitz; Ran Balicer; Eitan Bachmat; Noa Dagan
Source: check_circle
Ben-Gurion University of the Negev - Pure
grade
Preferred source (of 2)‎

ICU Survival Prediction Incorporating Test-Time Augmentation to Improve the Accuracy of Ensemble-Based Models

IEEE Access
2021-01-01 | Journal article | Author
DOI: 10.1109/ACCESS.2021.3091622
SOURCE-WORK-ID:

b0e4c636-9f33-4288-8cb8-9585c771e356

EID:

2-s2.0-85117579413
Contributors: Seffi Cohen; Noa Dagan; Nurit Cohen-Inger; Dan Ofer; Lior Rokach
Source: check_circle
Ben-Gurion University of the Negev - Pure
grade
Preferred source (of 2)‎

Performing risk stratification for COVID-19 when individual level data is not available – the experience of a large healthcare organization

medRxiv
2020 | Other
DOI: 10.1101/2020.04.23.20076976
EID:

2-s2.0-85098609618
Contributors: Barda, N.; Riesel, D.; Akriv, A.; Levi, J.; Finkel, U.; Yona, G.; Greenfeld, D.; Sheiba, S.; Somer, J.; Bachmat, E. et al.
Source: Self-asserted source
Noa Dagan via Scopus - Elsevier

Developing a COVID-19 mortality risk prediction model when individual-level data are not available

Nature Communications
2020-12-01 | Journal article | Author
DOI: 10.1038/s41467-020-18297-9
SOURCE-WORK-ID:

9c195cc6-8311-4797-80cd-f62f783a236c

EID:

2-s2.0-85090324118

PMID: 32895375
Contributors: Noam Barda; Dan Riesel; Amichay Akriv; Joseph Levy; Uriah Finkel; Gal Yona; Daniel Greenfeld; Shimon Sheiba; Jonathan Somer; Eitan Bachmat et al.
Source: check_circle
Ben-Gurion University of the Negev - Pure
grade
Preferred source (of 2)‎

Maternal age and cardiovascular and metabolic disease outcomes

Journal of Maternal-Fetal and Neonatal Medicine
2020-06-02 | Journal article | Author
DOI: 10.1080/14767058.2018.1531844
SOURCE-WORK-ID:

a4735d80-6be4-4382-a399-ae754ac19d1d

EID:

2-s2.0-85059004492

PMID: 30278799
Contributors: Becca Feldman; Sharon Orbach-Zinger; Maya Leventer-Roberts; Moshe Hoshen; Noa Dagan; Ran Balicer; Leonid A. Eidelman
Source: check_circle
Ben-Gurion University of the Negev - Pure
grade
Preferred source (of 3)‎

A score-based risk model for predicting severe COVID-19 infection as a key component of lockdown exit strategy

2020-05-23 | Working paper | Author
DOI: 10.1101/2020.05.20.20108571
SOURCE-WORK-ID:

013e85a7-28a8-4745-b27d-9cd4ec30a412
Contributors: Noa Dagan; Noam Barda; D. Riesel; Itamar Grotto; S. Sadetzki; Ran Balicer; Ran Balicer
Source: check_circle
Ben-Gurion University of the Negev - Pure
grade
Preferred source (of 3)‎

Automated opportunistic osteoporotic fracture risk assessment using computed tomography scans to aid in FRAX underutilization

Nature Medicine
2020-01-01 | Journal article | Author
DOI: 10.1038/s41591-019-0720-z
SOURCE-WORK-ID:

12e9edab-4af6-4f7f-bc4f-c4b42e08b894

EID:

2-s2.0-85077786029

PMID: 31932801
Contributors: Noa Dagan; Eldad Elnekave; Noam Barda; Orna Bregman-Amitai; Amir Bar; Mila Orlovsky; Eitan Bachmat; Ran D. Balicer
Source: check_circle
Ben-Gurion University of the Negev - Pure
grade
Preferred source (of 3)‎

Translating clinical trial results into personalized recommendations by considering multiple outcomes and subjective views

npj Digital Medicine
2019-12-01 | Journal article | Author
DOI: 10.1038/s41746-019-0156-3
SOURCE-WORK-ID:

724badf2-c3d4-434e-9fb5-5b1d2a4a7311

EID:

2-s2.0-85104074131
Contributors: Noa Dagan; Chandra J. Cohen-Stavi; Meytal Avgil Tsadok; Morton Leibowitz; Moshe Hoshen; Tomas Karpati; Amichay Akriv; Ilan Gofer; Harel Gilutz; Eduardo Podjarny et al.
Source: check_circle
Ben-Gurion University of the Negev - Pure
grade
Preferred source (of 2)‎

External validation and comparison of three prediction tools for risk of osteoporotic fractures using data from population based electronic health records

BMJ
2017-01-01 | Journal article | Author
DOI: 10.1136/bmj.i6755
SOURCE-WORK-ID:

246f1529-b180-46a6-b8ed-7643b9fdc5a5

EID:

2-s2.0-85009999890

PMID: 28104610
Contributors: Noa Dagan; Chandra Cohen-Stavi; Maya Leventer-Roberts; Ran D. Balicer
Source: check_circle
Ben-Gurion University of the Negev - Pure
grade
Preferred source (of 3)‎

Effects of social network exposure on nutritional learning

JMIR Serious Games
2015-07-01 | Journal article | Author
DOI: 10.2196/games.4002
SOURCE-WORK-ID:

c5acc209-5b7d-4463-9737-b180664da0e0

EID:

2-s2.0-85017900149
Contributors: Noa Dagan; Daniel Beskin; Mayer Brezis; Ben Y. Reis
Source: check_circle
Ben-Gurion University of the Negev - Pure
grade
Preferred source (of 3)‎

Erbin is a negative modulator of cardiac hypertrophy

Proceedings of the National Academy of Sciences of the United States of America
2014-04-22 | Journal article | Author
DOI: 10.1073/pnas.1320350111
SOURCE-WORK-ID:

fc1a4758-8c92-4c95-818e-4f33f5c9f28a

EID:

2-s2.0-84899079029

PMID: 24711380
Contributors: Inbal Rachmin; Sagi Tshori; Yoav Smith; Amit Oppenheim; Sylvie Marchetto; Gillian Kay; Roger S.Y. Foo; Noa Dagan; Eliahu Golomb; Dan Gilon et al.
Source: check_circle
Ben-Gurion University of the Negev - Pure
grade
Preferred source (of 3)‎

Surgical site infections following craniotomy focusing on possible post-operative acquisition of infection

European Journal of Clinical Microbiology and Infectious Diseases
2013-12-01 | Journal article | Author
DOI: 10.1007/s10096-013-1904-y
SOURCE-WORK-ID:

c69b2632-0370-4dd5-b4cc-6bc106bfe3b3

EID:

2-s2.0-84887999471

PMID: 23754309
Contributors: O. Sneh-Arbib; A. Shiferstein; Noa Dagan; S. Fein; L. Telem; E. Muchtar; N. Eliakim-Raz; B. Rubinovitch; G. Rubin; Z. H. Rappaport et al.
Source: check_circle
Ben-Gurion University of the Negev - Pure

Effectiveness of AZD7442 (Tixagevimab/Cilgavimab) for Pre-Exposure Prophylaxis Against COVID-19 Hospitalization in Israel During the Omicron Sub-Variant Time Period

Infectious Diseases and Therapy
Journal article | Author
DOI: 10.1007/s40121-024-01100-3
SOURCE-WORK-ID:

301bd446-4405-4077-be65-d562845dd314

EID:

2-s2.0-85214205093

PMID: 39762664
Contributors: Samah Hayek; Joseph Levy; Galit Shaham; Noa Dagan; Danielle Serby; Hadar Duskin-Bitan; Sabada Dube; Cátia Ferreira; Idit Livnat; Carla Talarico et al.
Source: check_circle
Ben-Gurion University of the Negev - Pure

Short-term Adverse Events after the Third Dose of the BNT162b2 mRNA COVID-19 Vaccine in Adults 60 Years or Older

JAMA network open
Journal article | Author
DOI: 10.1001/jamanetworkopen.2022.7657
SOURCE-WORK-ID:

4144f2c5-588b-4317-b453-516a02a67193

EID:

2-s2.0-85128796885

PMID: 35435973
Contributors: Oren Auster; Uriah Finkel; Noa Dagan; Noam Barda; Alon Laufer; Ran D. Balicer; Shay Ben-Shachar
Source: check_circle
Ben-Gurion University of the Negev - Pure

Peer review (5 reviews for 3 publications/grants)

Review activity for Nature aging. (1)
Review activity for Nature medicine. (3)
Review activity for npj digital medicine. (1)
How many people are using ORCID?